WeChat Mini Program
Old Version Features

VX-509, An Orally Available Janus Kinase 3 (JAK3) Specific Inhibitor, Showed Robust Activity in Pre-Clinical Models of Aberrant Immune/Inflammatory Function

Thomas Hoock,James Hogan,Sudipta Mahajan,Dina Shlyakhter,Luke Oh,Larry Park,George Ku, Ian Catlett, Meryll Corbin,Francesco Salituro,Mark Namchuk

ARTHRITIS AND RHEUMATISM（2011）

Cited 1|Views3
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined